TBC and COVID: an interplay between two infections

G Murdaca, F Paladin, G Mangini, D Tiso… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction In a historical era dominated by the SARS-CoV-2 pandemic, a fact of growing
interest emerges regarding co-infection with Mycobacterium tuberculosis (M. tuberculosis) …

Results of a 12-Week Open-Label, Non-Interventional Study of the Efficacy and Safety of Olokizumab Therapy in Patients with Rheumatoid Arthritis after Switching …

AA Akimova, NE Banshchikova, AE Sizikov… - Doklady Biochemistry …, 2024 - Springer
Absttact—The COVID-19 pandemic has significantly changed the understanding of the
safety profile of therapies for immunoinflammatory rheumatic diseases (IRDs). This is …

Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models

HY Zheng, TZ Song, YT Zheng - Zoological research, 2024 - pubmed.ncbi.nlm.nih.gov
The distribution of the immune system throughout the body complicates in vitro assessments
of coronavirus disease 2019 (COVID-19) immunobiology, often resulting in a lack of …

[PDF][PDF] Cytokine Levels and Severity of Illness Scoring Systems to Predict Mortality in COVID-19 Infection. Healthcare 2023, 11, 387

S Onuk, H Sipahioglu, S Karahan, A Yesiltepe… - 2023 - academia.edu
Various scoring systems and cytokines have been cited as predicting disease severity in
COVID-19 infection. This study analyzed the link between mortality rate, levels of cytokines …

[PDF][PDF] Développement d'un vaccin à spectre élargi de protection contre le SRAS-CoV-2

LJ Blanchette - 2023 - corpus.ulaval.ca
Résumé La pandémie de COVID-19 a suscité d'intenses efforts de vaccination pour
neutraliser le SRAS-CoV-2 en réduisant la transmission et la mortalité. Cependant, la …

[PDF][PDF] In Silico Analysis of Flavonoid Potential as Inhibitors of Interleukin-6 (IL-6) and Tumor Necrosis Factor-Alpha (TNF-α) in Managing Cytokine Storm

MD Hanifan, M Sariyanti, B Sinuhaji… - J Pharm Sci Drug …, 2024 - manuscriptscientific.com
Abstract Interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) exert the greatest
influence on cytokine cascades via the nuclear factor-kappa B (NF-B) and janus …

Luteolin and Chrysin as Inhibitors of SARS-CoV-2 Infection

K Pearce, B Fielding - Anti-SARS-CoV-2 Activity of Flavonoids - taylorfrancis.com
Flavonoids continue to play an important role in drug discovery and are increasingly being
explored as potential antiviral therapeutics. These compounds often present distinct …

Parameter changes of COVID-19 incidence in Baghdad/Iraq in 2020: Infected and cured individuals: A retrospective single center study

N Mahmood, Z Abdulghany - Health Biotechnology and …, 2024 - healthbiotechpharm.org
Coronavirus disease 2019 (COVID-19) represented a highly respiratory syndrome to
worldwide. Aim of current research was to determine the changes in hematology and …

Effects of Infliximab on patients with COVID-19: a systematic review and meta-analysis

A Ataei, A Orandi, ES Malekabad, MH Sharbafi… - 2024 - advance.sagepub.com
Despite the control of the COVID-19 pandemic, it remains one of the main concerns of
healthcare systems throughout the world. Inflammation and hyper-reactive immune system …

[PDF][PDF] Perturbations hématologiques associées à la sévérité et à la mortalité de la COVID-19: étude monocentrique sur 90 cas colligés à Ouagadougou, Burkina Faso …

S SAWADOGO - researchgate.net
L'objectif de notre étude était de décrire les perturbations hématologiques au cours de la
COVID-19 et leur association avec la sévérité et la mortalité de la maladie. Nous avons …